Works by Novitasari, Dhania
Results: 14
Cytoprotective Properties of Turmeric Oil (Curcuma longa L.) on Fibroblast Cells.
- Published in:
- Asian Pacific Journal of Cancer Prevention, 2024, v. 25, n. 11, p. 4005, doi. 10.31557/APJCP.2024.25.11.4005
- By:
- Publication type:
- Article
The anti-migratory activity of a new curcumin analog, CCA-1.1, against T47D breast cancer cells.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 2877, doi. 10.31838/ijpr/2021.13.01.421
- By:
- Publication type:
- Article
A new curcumin analog, CCA-1.1, induces cell cycle arrest and senescence toward ER-positive breast cancer cells.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2021, v. 13, n. 1, p. 1, doi. 10.31838/ijpr/2021.13.01.002
- By:
- Publication type:
- Article
Pentagamavunone-1 Suppresses MYCN-Positive HuH-7 Cancer Cell Growth Via Mitotic Arrest In Vitro.
- Published in:
- Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2024, v. 35, n. 4, p. 649
- By:
- Publication type:
- Article
Network Pharmacological Analysis Identifies the Curcumin Analog CCA-1.1 Targeting Mitosis Regulatory Process in HER2-Positive Breast Cancer.
- Published in:
- Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2023, v. 34, n. 1, p. 54
- By:
- Publication type:
- Article
Bioinformatic and Molecular Interaction Studies Uncover That CCA-1.1 and PGV-1 Differentially Target Mitotic Regulatory Protein and Have a Synergistic Effect against Leukemia Cells.
- Published in:
- Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2022, v. 33, n. 2, p. 225
- By:
- Publication type:
- Article
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties.
- Published in:
- Advanced Pharmaceutical Bulletin, 2022, v. 12, n. 3, p. 603, doi. 10.34172/apb.2022.063
- By:
- Publication type:
- Article
Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studies.
- Published in:
- Journal of Advanced Pharmaceutical Technology & Research, 2023, v. 14, n. 4, p. 317, doi. 10.4103/JAPTR.JAPTR_315_23
- By:
- Publication type:
- Article
Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer.
- Published in:
- Journal of Advanced Pharmaceutical Technology & Research, 2022, v. 13, n. 1, p. 70, doi. 10.4103/japtr.japtr_220_21
- By:
- Publication type:
- Article
The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC).
- Published in:
- Journal of the Egyptian National Cancer Institute, 2021, v. 33, n. 1, p. 1, doi. 10.1186/s43046-021-00077-1
- By:
- Publication type:
- Article
Coffee Bean and Its Chemical Constituent Caffeine and Chlorogenic Acid as Promising Chemoprevention Agents: Updated Biological Studies against Cancer Cells.
- Published in:
- Molecules, 2024, v. 29, n. 14, p. 3302, doi. 10.3390/molecules29143302
- By:
- Publication type:
- Article
Molecular Mechanism of Natural Food Antioxidants to Regulate ROS in Treating Cancer: A Review.
- Published in:
- Antioxidants, 2024, v. 13, n. 2, p. 207, doi. 10.3390/antiox13020207
- By:
- Publication type:
- Article
Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells.
- Published in:
- Research in Pharmaceutical Sciences, 2023, v. 18, n. 4, p. 358, doi. 10.4103/1735-5362.378083
- By:
- Publication type:
- Article
The Combination of Sorafenib and PGV‐1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c‐Myc Suppression in an Additive Manner: In Vitro Studies.
- Published in:
- Advances in Pharmacological & Pharmaceutical Sciences, 2024, v. 2024, p. 1, doi. 10.1155/adpp/4297953
- By:
- Publication type:
- Article